These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9203661)

  • 1. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.
    Probert WS; Crawford M; Cadiz RB; LeFebvre RB
    J Infect Dis; 1997 Feb; 175(2):400-5. PubMed ID: 9203661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
    Probert WS; LeFebvre RB
    Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
    Fikrig E; Tao H; Barthold SW; Flavell RA
    Infect Immun; 1995 May; 63(5):1658-62. PubMed ID: 7729870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
    Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.
    Wilske B; Jauris-Heipke S; Lobentanzer R; Pradel I; Preac-Mursic V; Rössler D; Soutschek E; Johnson RC
    J Clin Microbiol; 1995 Jan; 33(1):103-9. PubMed ID: 7699024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
    Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y
    Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R
    Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development.
    Wilske B; Busch U; Fingerle V; Jauris-Heipke S; Preac Mursic V; Rössler D; Will G
    Infection; 1996; 24(2):208-12. PubMed ID: 8740124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of Borrelia burgdorferi outer surface protein C under immune selection pressure.
    Hodzic E; Feng S; Barthold SW
    J Infect Dis; 2000 Feb; 181(2):750-3. PubMed ID: 10669369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic passive vaccination against chronic Lyme disease in mice.
    Zhong W; Stehle T; Museteanu C; Siebers A; Gern L; Kramer M; Wallich R; Simon MM
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12533-8. PubMed ID: 9356484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
    Jacquet M; Durand J; Rais O; Voordouw MJ
    Infect Genet Evol; 2015 Dec; 36():131-140. PubMed ID: 26384476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W; Gern L; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.
    Telford SR; Fikrig E; Barthold SW; Brunet LR; Spielman A; Flavell RA
    J Exp Med; 1993 Aug; 178(2):755-8. PubMed ID: 8340764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice.
    Bockenstedt LK; Fikrig E; Barthold SW; Kantor FS; Flavell RA
    J Immunol; 1993 Jul; 151(2):900-6. PubMed ID: 8335917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
    Lovrich SD; Callister SM; DuChateau BK; Lim LC; Winfrey J; Day SP; Schell RF
    Infect Immun; 1995 Jun; 63(6):2113-9. PubMed ID: 7768589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.